Day One Biopharmaceuticals (DAWN) Current Ratio

Price: $7.74
Market Cap: $784.48M
Avg Volume: 1.18M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: -1.247
52W Range: $6.41-18.07
Website: Day One Biopharmaceuticals

Day One Biopharmaceuticals Current Ratio

  • Annual: 7.66
  • Quarterly: 7.66
  • TTM: 7.66

What is the Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay off its short-term liabilities with its short-term assets. A higher current ratio indicates a greater ability to meet short-term obligations.

Related Metrics

Other important metrics to assess Day One Biopharmaceuticals's financial health include:

  • Quick Ratio - measures the company's ability to meet short-term obligations with its most liquid assets:
    • Annual: 7.61
    • Quarterly: 7.61
    • TTM: 7.61
  • Cash Ratio - measures the company's ability to pay off short-term liabilities with cash and cash equivalents:
    • Annual: 1.70
    • Quarterly: 1.70
    • TTM: 1.70

These metrics provide insights into Day One Biopharmaceuticals's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Current Ratio

7.66

Quarterly Current Ratio

7.66

TTM Current Ratio

7.66

Day One Biopharmaceuticals Historical Current Ratio
40.0040.0032.0032.0024.0024.0016.0016.008.008.000.000.00Current Ratio202020202021202120222022202320232024202420252025
Historical Quick Ratio
40.0040.0032.0032.0024.0024.0016.0016.008.008.000.000.00Quick Ratio202020202021202120222022202320232024202420252025
Historical Cash Ratio
40.0040.0032.0032.0024.0024.0016.0016.008.008.000.000.00Cash Ratio202020202021202120222022202320232024202420252025

Day One Biopharmaceuticals Historical Ratios

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year Current Ratio Quick Ratio Cash Ratio
2024 7.66 7.61 1.70
2023 12.72 12.72 7.82
2022 20.94 20.94 5.13
2021 33.43 33.43 32.84
2020 22.58 22.58 21.91
2019 13.53 13.53 13.52

Related Metrics

Explore detailed financial metrics and analysis for DAWN.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio